相关实验视频
Updated: Jun 22, 2026
08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.4K
改变MET的非小细胞肺癌的免疫和基因组异质性
Manlu Liu1, Rachel L Minne2, Saahil Javeri2
1University of Wisconsin School of Medicine and Public Health, Madison, WI.
JCO precision oncology
|September 26, 2025
概括
这项研究揭示了非小细胞肺癌中MET外显子14跳转突变和MET放大的独特基因组和免疫特征. 了解这些差异是预测MET改变NSCLC患者免疫治疗反应的关键.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 非小细胞肺癌 (NSCLC) 患有MET外显子14跳转突变 (METex14) 或MET放大 (METamp) 的患者对免疫治疗的反应有变化.
- 了解MET改变NSCLC的基因组和免疫特征对于优化治疗策略至关重要.
研究的目的:
- 为了研究METex14和METamp的NSCLC患者的基因组和免疫资料.
- 为了确定瘤突变负担 (TMB),PD-L1表达和MET改变型和MET野生型NSCLC之间的免疫基因表达的差异.
主要方法:
- 分析基因组变异,TMB,PD-L1表达和免疫基因表达在3,841名NSCLC患者中,使用Strata Select试验.
- METex14,高METamp,低METamp,其他MET突变和MET野生型 (METwt) 组的比较.
- 分析MET变异腺癌中免疫基因表达的分析,具有可向的瘤驱动因素.
主要成果:
- METex14和METamp瘤表现出不同的基因组共同变异,包括TP53突变和MDM2放大 (METex14) 或CDKN2A (METamp).
- 瘤突变负担 (TMB) 不同,在METex14中最低,在其他MET突变中最高. 在METex14和METamp.中,PD-L1表达通常高.
- METex14显示了丰富的免疫环境,而METamp显示了免疫抑制的环境,METex14和低METamp具有更高的AXL基因表达.
结论:
- METex14和METamp具有独特的基因组和免疫特征,影响NSCLC的免疫治疗结果.
- 这些分子差异为在MET改变NSCLC的免疫治疗中观察到的不一致反应提供了洞察力.
- 需要进一步的研究来利用这些发现,改善MET改变NSCLC的治疗策略.
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
01:20Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...